2Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study[J]. Circulation, 2014,129(8):837-847.
3Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060[J], Eur Heart J, 2013,34(35): 2746-2751.
4Wong CX, Brooks AG, Leong DP, et al. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of ali hospitalizations in Australia[J]. Arch Intern Med, 2012,172(9): 739-741.
5Shroff GR, Solid CA, Herzog CA, et al. Temporal trends in ischemic stroke and antieoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992 2007)[J]. JAMA Intern Med, 2013,173(2) :159-160.
6O'Brien EC, Kim S, Hess PL,et al. Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation[J]. JAMA Intern Med, 2015,175(5) :848-850.
7Lip GY, Laroche C, Dan GA, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry[J]. Europace, 2014,16 (3) : 308-319.
8Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial[J]. JAMA, 2014, 312 (19): 1988- 1998.
9Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial {ibrillation[J]. N Engl J Med, 2015,372(19) : 1812-1822.
10Dong JZ, Sang CH, Yu RH, et al. Prospective randomized comparison between a fixed '2C3L' approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation [J]. Europace, 2015, May 8.[Epub ahead of print].
